Tag: from

New York City's mandatory measles vaccine orders trigger lawsuit from parents

Is the anti-vaccination movement to blame for the near-record number of measles cases? NEW YORK CITY – Five parents filed a lawsuit Monday against the New York City Department of Health claiming the city overstepped its authority by making vaccinations mandatory in neighborhoods experiencing the measles outbreak. The parents claimed last week’s orders violated their “children’s

Fake warnings on e-cigarette ads distract kids from truth

When it comes to marketing electronic cigarettes to young people, fake news appears to stick. The U.S. Food and Drug Administration currently requires a prominent warning about the dangers of nicotine for e-cigarettes. But just before that mandate, a 2017 campaign by e-cigarette maker blu included fake warnings in precisely the place the real warnings

Can being born blind protect people from schizophrenia?

A study carried out by The University of Western Australia has provided compelling evidence that congenital/early cortical blindness – that is when people are blind from birth or shortly after—is protective against schizophrenia. The unusual discovery has fascinated scientists and may lead to a better understanding of what causes schizophrenia – a question that has

Sleep apnea may stop you from forming life memories

Obstructive sleep apnea (OSA) is a sleep disorder that affects more than 18 million adults in the United States and over 100 million people worldwide. Those with the condition often have fragmented sleep because OSA interrupts their breathing briefly but repeatedly. OSA also lowers a person’s oxygen levels, and the combination of poor sleep and

Cancer has a biological clock and this drug may keep it from ticking

A new drug shows potential to halt cancer cells’ growth by stunting the cells’ biological clock. The findings from scientists at the USC Michelson Center for Convergent Bioscience and Nagoya University’s Institute of Transformative BioMolecules (ITbM) advance a burgeoning area of research: turning the body’s circadian rhythms against cancer. Their study, conducted on human kidney

Dengue virus immunity may protect children from Zika symptoms

Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues. Zika virus emerged in northeast Brazil in 2015 and spread rapidly across the Americas, affecting populations that have been largely

Study points to increased risk of harm from cannabis across Europe

Cannabis resin and herbal cannabis have significantly increased in potency and in price, according to the first study to investigate changes in cannabis across Europe. The study, published today in the journal Addiction by researchers from the University of Bath and King’s College London, draws on data collected from across 28 EU Member states, as

Palliative care in MS inpatients rises from 2005 to 2014

(HealthDay)—From 2005 to 2014, trends in palliative care use increased substantially among multiple sclerosis (MS) inpatients, according to a study published in the December issue of the Journal of Clinical Neuroscience. Yong-Jae Lee, Ph.D., from the Yonsei University College of Medicine in Seoul, South Korea, and colleagues used data from the 2005 to 2014 U.S.

Many Patients Withhold Information From Clinicians

TUESDAY, Dec. 4, 2018 — Many patients intentionally withhold information from clinicians, according to a study published online Nov. 30 in JAMA Network Open. Andrea Gurmankin Levy, Ph.D., from Middlesex Community College in Middletown, Connecticut, and colleagues recruited two national nonprobability samples (Amazon’s Mechanical Turk [MTurk], 2,096 respondents, and Survey Sampling International [SSI], 3,011 respondents)

Dana-Farber to present research on myeloma progression from precursor conditions

Dana-Farber Cancer Institute scientists will present research marking significant advances against the hematologic cancer multiple myeloma at the American Society of Hematology (ASH) Annual Meeting Dec. 1-4. Their findings provide new insights into the progression of the disease from precursor conditions and suggest approaches for novel treatments. In related work, Dana-Farber investigators will also present